The Commission)

This procedure establishes the rules for the authorization, supervision, and distribution of medicines for human use across the EU. It aims to ensure that pharmaceutical products are safe, effective, and available to patients throughout the Union by harmonizing standards and granting implementing powers to the European Commission.

This affects pharmaceutical companies, healthcare providers, and patients. It streamlines how medicines are approved for the market and ensures consistent safety monitoring across all member states.